trial
as of 2026-07-01Novel Candidate Genes for Treatment Response to Antipsychotics in Schizophrenia
NCTId NCT02205437
at a glance
Phase — · Unknown
Enrollment 200 (estimated)
Sponsored by Fundación Marques de Valdecilla
Primary completion 2020-12
Synthesized from structured facts only — each point cited above.
Design & status
Phase
—
Status
Unknown
Enrollment
200 (estimated)
Study type
Observational
Allocation
—
Model
—
Masking
—
Start
2015-01
Primary completion
2020-12
Eligibility
ALL · 15 Years · 60 Years
Interventions & indications
Drugs
—
Sponsors
Fundación Marques de ValdecillaLead Sponsor
Instituto de Investigación Marqués de ValdecillaCollaborator
Investigators
1
Benedicto Crespo-Facorro, ProfessorPrincipal Investigator
Sites
1 total
Santander, Spain
Facts & assertions
4 sourced
Enrollment
200
Phase
NA
Primary Completion Date
2020-12
Status
UNKNOWN
relationships
The graph out of here
lead_sponsor
collaborator
indication
investigator